HOME >> MEDICINE >> NEWS
First quarter prescription drug spending: Generic drugs slow upward trend

ST. LOUIS, June 3, 2003 -- Growth in prescription drug spending slowed to 11.3% during first quarter 2003 as consumers used more wallet-friendly generic drugs and, as a result of a mild flu season, fewer antihistamines and cough-cold remedies. Lower, too, was use of estrogen drugs because of safety concerns raised by studies published last year.

According to pharmacy benefit manager Express Scripts, during the previous year first quarter, spending grew at a much faster 16.9% rate. The company, which serves over 50 million consumers, announced the first quarter drug spending data today at its annual research Outcomes Conference here.

Other research presented at the conference found that physicians welcome and act on information presented to them regarding potential safety hazards involving prescriptions they have written. A significant number 38% said they changed or modified their patient's therapy as a result of the information.

Commenting on the slowdown in prescription drug spending, Express Scripts Chief Executive Officer Barrett Toan said, "The drops in antihistamine, cough-cold and estrogen drug utilization were one-time events, but the cost-reducing effect of expanding generic drug use will continue to help make prescription drugs much more affordable for years to come."

Greater use of generic drugs reduced the dollar outlay for prescription drugs by 3.2% during the first quarter and, for all of 2002, by 2.1%. During the first quarter 2003, 47% of all prescription claims processed by Express Scripts were for generic drugs, up from 43% a year earlier.

During the next five years, patents will expire on brand-name drugs representing $32.3 billion in U.S. sales last year. For example, this year, the ACE inhibitor Monopril and the cancer drug Nolvadex are among the brand-name drugs scheduled for patent expiration. The 2004 patent expiration list includes the antibiotic Cipro and the anti-depressant Celexa, among oth
'"/>

Contact: Steve Littlejohn
slittlejohn@express-scripts.com
314-702-7556
Kupper Parker Communications
3-Jun-2003


Page: 1 2 3 4

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First US SARS vaccine trial opens at NIH
9. First-ever safety study of medical cannabis use in Canada launched
10. First solid evidence that the study of music promotes intellectual development
11. First medical test on CD gets good results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... October 17, 2019 , ... Dr. Parsa Mohebi, the ... Angeles and Beverly Hills, is reminding patients interested in undergoing a hair transplant that ... , According to Dr. Mohebi, “The holidays are a time for friends and family ...
(Date:10/15/2019)... Va. (PRWEB) , ... October 15, 2019 , ... ... Complying with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, October ... recent Instructions for Use (IFU) guidance have on new drug applications and biologics ...
(Date:10/11/2019)... ... October 11, 2019 , ... Inland Detox, Inc. has just moved ... location has incredible views of the Temecula Valley and it’s the perfect place for ... facility offers both private rooms as well as double occupancy rooms, a 2nd home ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Annual Conference, Nutrition 21 was excited to hear the significant results of an ... blood flow impact of Nitrosigine®. The clinical study poster entitled “The Acute Effects ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon ... Jose, CA experience relief from this common and treatable condition. Dr. HagShenas’ goal is ... adults from living with uncomfortable symptoms, including tender and bleeding gums, and to prevent ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... ... ... Hospital M&A activity held steady with 21 transactions in both the second and ... quarter was down 20% compared with the same period in 2018, when 25 deals ... $5.0 billion, a 291% increase. Year over year, Q3:19 spending was down 41% versus ...
(Date:10/17/2019)... (PRWEB) , ... October 17, 2019 , ... ... a patient receiving the right treatment before it progresses further. With many patients ... resources that can help their correct identification of skin cancer be extremely valuable. ...
(Date:10/11/2019)... ... 11, 2019 , ... The 'W' Initiative, a flagship women ... Health Month. The plans are aimed at improving community awareness on health issues ... to health checks and encouraging healthy lifestyle habits. , Slated to run all ...
Breaking Medicine Technology:
Cached News: